Cargando…
Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients
Fluorouracil (5-FU) has been wildly used as a primary medication in the treatment of solid tumors including colorectal cancer. The treatment efficacy and toxicity of 5-FU varies greatly among individuals, suggesting a need for individualized regimen for cancer patients. The present study analyzed th...
Autores principales: | Fang, Ling, Jiang, Yi, Yang, Yuxian, Zheng, Yuqiong, Zheng, Jin, Jiang, Hong, Zhang, Shengqi, Lin, Lifang, Zheng, Jieting, Zhang, Shuyao, Zhuang, Xiaowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348438/ https://www.ncbi.nlm.nih.gov/pubmed/27636992 http://dx.doi.org/10.18632/oncotarget.11980 |
Ejemplares similares
-
Combined Therapeutic Effects of (131)I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
por: Wu, Pingping, et al.
Publicado: (2020) -
Neglected, Drug-Induced Platinum Accumulation Causes Immune Toxicity
por: Zhang, Yuling, et al.
Publicado: (2020) -
GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death
por: Zhang, Zizhen, et al.
Publicado: (2021) -
Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019) -
The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)